See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Liberation Day
Donald Trump
Natural Disasters
Trade War
Social Media
Stock Markets
Trade
Taxes
Climate Change
Artificial Intelligence
Nintendo
Published • loading... • Updated

StockNews.com Downgrades Cameco (NYSE:CCJ) to Sell

Summary by themarketsdaily.com
Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a report issued on Wednesday. Other research analysts also recently issued reports about the stock. Stifel Canada upgraded shares of Cameco to a “strong-buy” rating in a research report on Wednesday, March 12th. Stifel Nicolaus […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

All
Left
Center
Right
wkrb13.comwkrb13.com

Werner Enterprises (NASDAQ:WERN) Lowered to “Sell” Rating by StockNews.com

Werner Enterprises (NASDAQ:WERN – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday. WERN has been the topic of several other research reports. Wells Fargo & Company reduced their price target on shares of Werner Enterprises from $34.00 […]

Read Full Article
themarketsdaily.comthemarketsdaily.com

StockNews.com Downgrades Cameco (NYSE:CCJ) to Sell

Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a report issued on Wednesday. Other research analysts also recently issued reports about the stock. Stifel Canada upgraded shares of Cameco to a “strong-buy” rating in a research report on Wednesday, March 12th. Stifel Nicolaus […]

Read Full Article
modernreaders.commodernreaders.com

StockNews.com Downgrades Akebia Therapeutics (NASDAQ:AKBA) to Sell

Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a report issued on Wednesday. Several other equities analysts also recently issued reports on the company. Piper Sandler upped their target price on Akebia Therapeutics from $4.00 to $6.00 and gave the company an “overweight” rating in a research report on Friday, March 14th. Jefferies Financial Grou…

Read Full Article
watchlistnews.comwatchlistnews.com

Ichor (NASDAQ:ICHR) Raised to “Hold” at StockNews.com

Ichor (NASDAQ:ICHR – Get Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a report released on Wednesday. ICHR has been the subject of a number of other reports. Needham & Company LLC restated a “hold” rating on shares of Ichor in a research note on […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

watchlistnews.com broke the news in on Thursday, April 3, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal